Evidence map›Paper›PMID 39367109›Full record

ArticleScientific reports2024

A near normal distribution of IQ in Fragile X Syndrome.

Lauren M Schmitt, Meredith Nelson, Rebecca C Shaffer, Craig A Erickson

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Lauren M SchmittCincinnati Children's Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH, 45229- 3039, USA. lauren.schmitt@cchmc.org.
Meredith NelsonUniversity of Cincinnati College of Medicine, 3333 Burnet Ave, Cincinnati, OH, 45229-3039, USA.
Rebecca C ShafferCincinnati Children's Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH, 45229- 3039, USA.
Craig A EricksonCincinnati Children's Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH, 45229- 3039, USA.

Funding

Neurophysiological and acute pharmacological studies in FXS patientsU54HD082008 · NICHD · UT SOUTHWESTERN MEDICAL CENTER · PI HUBER, KIMBERLY M. · 2014 to 2019
$9.8M
Translational medicine and mechanistic studies of brain neurophysiology in Fragile X SyndromeU54HD104461 · NICHD · CINCINNATI CHILDRENS HOSP MED CTR · PI HUBER, KIMBERLY M. · 2020 to 2024
$8.1M
Electrophysiological Biomarkers of Neurocognitive Deficits in Fragile X SyndromeK23HD101416 · NICHD · CINCINNATI CHILDRENS HOSP MED CTR · PI SCHMITT, LAUREN · 2020 to 2024
$617k
National Institute of Child Health and Human Development K23HD101416National Institute of Child Health and Human Development U54HD082008NICHD NIH HHS K23 HD101416NICHD NIH HHS U54 HD082008NICHD NIH HHS U54 HD104461
6 · The paper itself

Abstract

Fragile X Syndrome (FXS) is an X-linked disorder leading to the loss of expression of FMR1-protein product, FMRP. The absence or deficiency of FMRP is thought to result in the characteristic FXS phenotypes, including intellectual disability. Identifying the relationship between FMRP levels and IQ may be critical to better understand underlying mechanisms and advance treatment development and planning. A sample of 143 individuals with FXS (69% male), aged 8-50 years, completed IQ testing and blood draw via venipuncture to determine the relationship between Deviation IQ scores and FMRP levels as well as the distribution of Deviation IQ scores. In both males and females with FXS, higher FMRP levels were associated with higher Deviation IQ. However, this relationship was no longer significant when only examining full mutation, fully-methylated males. Yet, both the full and restricted male samples showed a downward shifted but otherwise normal distribution of Deviation IQ scores. Our findings support and extend previous studies establishing molecular markers of disease severity in FXS as well as provide novel evidence of a "FXS IQ standard curve". This latter finding suggests inter-individual variation in Deviation IQ in FXS, especially among males, may be driven by similar factors known to impact cognitive outcomes in typically-developing individuals. Thus, future work aimed at understanding the mechanisms by which FMRP loss leads to intellectual disability should revisit the biological/genetic, socio-environmental, and epigenetic factors contributing to inter-individual variation in IQ in FXS.

Indexed as

Fragile X Messenger Ribonucleoprotein 1Fragile X SyndromeIntelligenceAdolescentAdultChildFemaleHumansIntellectual DisabilityIntelligence TestsMaleMiddle AgedMutationYoung AdultFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1

Identifiers

PMID39367109
PMCPMC11452685

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.